Research article

Impact of patient characteristics on the risk of influenza/ILI-related complications

Debra E Irwin¹, Lisa B Weatherby¹, Wen-Yi Huang^2,³, Daniel M Rosenberg⁴, Suzanne F Cook² and Alexander M Walker¹^*

¹ Ingenix Pharmaceutical Services, Epidemiology Division, Newton Lower Falls, Massachusetts, USA

² Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USA

³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA

⁴ Worldwide Epidemiology, GlaxoSmithKline, Greenford, UK

For all author emails, please log on.

BMC Health Services Research 2001, 1:8 doi:10.1186/1472-6963-1-8

Published: 21 August 2001

Supplementary files:

Appendix A: ICD-9 Codes for influenza-Related Complications and Manifestations.Contents are as name implies.

Appendix B: Comorbidities for Influenza.Defines disease states in terms of requisite codes.

Format: DOC Size: 67KB Format: DOC Size: 33KB Download file

This file can be viewed with: Microsoft Word Viewer